Director, Oligonucleotide Manufacturing

Dyne Therapeutics•Waltham, MA
•$200,000 - $240,000•Onsite

About The Position

The Director, Oligonucleotide Manufacturing, translates Dyne’s CMC and program strategy into integrated manufacturing plans for oligonucleotide payloads from late-stage clinical development through commercial launch. The role leads external manufacturing strategy and execution, including CDMO selection and governance, technology transfer, scale-up, capacity planning, supply continuity, and cost management. The Director sets operational priorities, performance expectations, and risk-mitigation plans to support robust, scalable, compliant, and cost-effective manufacturing. Working across Research, Regulatory, Quality, Clinical, Finance, and other functions in a matrixed environment, the Director leads cross-functional decision-making, advises senior leadership on manufacturing strategy and investment tradeoffs, and strengthens Dyne’s internal CMC capabilities. The role is based onsite in Waltham, Massachusetts, with no remote option.

Requirements

  • Advanced degree in Chemistry, Biochemistry, Chemical Engineering, Pharmaceutical Sciences, or a related discipline.
  • 10+ years of progressive experience in oligonucleotide manufacturing and CMC, including hands-on experience with oligonucleotide payloads, oligonucleotide-based therapeutics, and conjugates.
  • Experience translating program or CMC strategy into manufacturing plans, priorities, budgets, timelines, and risk-mitigation actions.
  • Significant experience selecting, governing, and influencing CDMOs, with accountability for cGMP performance, quality, compliance, cost, and supply outcomes.
  • Experience leading technology transfer, scale-up, validation, and late-stage clinical manufacturing.
  • Strong business and financial acumen, including forecasting, external manufacturing spend, resource planning, and investment tradeoffs.
  • Ability to lead complex cross-functional work, reconcile competing priorities, and influence decisions without direct authority.
  • Experience establishing governance, operating standards, and scalable processes, and building capability through coaching, knowledge transfer, or team development.
  • Strong knowledge of pharmaceutical and biotechnology industry trends, product development and life cycle management, global regulatory requirements, and clinical-stage manufacturing.
  • Strong judgment, facilitation, negotiation, and problem-solving skills, including the ability to make and communicate recommendations on complex technical and business matters.
  • Excellent verbal, written, and presentation skills; ability to communicate effectively with senior leaders, cross-functional teams, regulators, contractors, and external partners.
  • Ability to operate independently, lead in a matrixed environment, and adapt priorities as business and program needs evolve.

Nice To Haves

  • Commercial launch experience.

Responsibilities

  • Translate CMC and program strategy into manufacturing plans, priorities, budgets, resource requirements, timelines, and risk-mitigation actions for late-stage clinical and commercial supply.
  • Lead oligonucleotide payload manufacturing from late-stage clinical development through commercial launch, setting functional objectives, operational targets, and milestones.
  • Select, qualify, and govern external CDMOs, setting expectations and accountability for quality, compliance, cost, service, and delivery.
  • Ensure continuity of clinical and commercial supply through capacity planning, demand and supply alignment, scenario planning, and proactive risk mitigation.
  • Develop forecasts, manage external manufacturing spend, evaluate investment options, and recommend cost, capacity, and sourcing tradeoffs.
  • Lead technology transfer, scale-up, process validation, process improvements, and resolution of manufacturing issues across external partners.
  • Review and approve cGMP documentation, including technology-transfer, process and analytical development and validation reports, qualification protocols and reports, validation master batch records, and campaign summary reports.
  • Prepare and review CMC sections for global regulatory submissions, including INDs, IMPDs, and BLAs; support responses to health authority questions and inspections.
  • Lead cross-functional decision-making to define compliant, scientifically sound, and executable CMC strategies.
  • Advise senior leadership on manufacturing strategy, partner performance, supply risk, capacity, investment needs, and technical or business tradeoffs.
  • Build scalable internal CMC and manufacturing capabilities through resource planning, knowledge transfer, standards and processes, and coaching.
  • Evaluate and implement emerging technologies and external capabilities to improve product quality, process performance, scalability, and cost effectiveness.
  • Prepare and deliver technical documentation, governance updates, publications, and presentations for internal and external audiences.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service